Business

Shareholders approve Cigna’s $60 billion purchase of Express Scripts

By Joe Williams
Published August 24, 2018 4:29pm ET
Add Washington Examiner on Google
Shareholders approve Cigna’s $60 billion purchase of Express Scripts
Total revenues for Cigna in 2017 were $41.6 billion, an increase of 5 percent over 2016, driven by continued growth in Cigna's targeted customer segments. | (Michael Nagle/Bloomberg)

Cigna Corp. and Express Scripts shareholders on Friday approved the insurer’s $60 billion acquisition of the pharmacy benefit manager, following a top activist investor’s decision to drop his opposition to the transaction.

Regulatory approval for the deal remains pending, but the companies expect it to close by the end of 2018.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Insurance Industry